Mississippi's attorney general asks the Supreme Court to overturn Roe v Wade; the Biden administration releases more COVID-19 funds to combat the delta variant; Missouri Supreme Court rules to expand health care access.
Mississippi’s attorney general is urging the Supreme Court to overturn Roe v. Wade, the ruling that secured a woman’s right to an abortion, The New York Times reports. Calling the decision “egregiously wrong,” Attorney General Lynn Fitch hopes to sustain a state law that bans most abortions after 15 weeks of pregnancy. The conservative-majority Supreme Court is scheduled to hear arguments on the case in the fall, while lower courts have previously blocked the Mississippi statute. Fitch has argued the scope of abortion rights should be determined through the political process.
Following increasing rates of COVID-19 infections, hospitalizations, and deaths seen across the United States, the White House announced new funds for COVID-19 testing and vaccination will be released, according to The Hill. In particular, about $100 million in new funds will be directed at rural health clinics to aid in vaccine outreach, as these are often located in areas with low vaccination rates and may be more trusted among community members. An additional $1.6 billion will go toward testing in prisons and homeless and domestic violence shelters. The money will come out of the American Rescue Plan relief package.
The Missouri Supreme Court ruled an additional 270,000 low-income individuals will now be eligible for publicly funded health care, NPR reports. Although voters in the state had previously approved a constitutional amendment to adopt Medicaid expansion, the Republican-led legislature declined to implement it. Following this refusal, Governor Mike Parson (R) stopped the plans to bolster the state's health care system. But in an unanimous opinion, the state’s Supreme Court ruled new Medicaid recipients would join the existing pool of beneficiaries in the state.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More